The FINANCIAL — The ADVANCE (Accelerating Discovery: Actionable NASH Cirrhosis Endpoints) study will follow 200 patients with cirrhosis – scarring caused by long-term damage of the liver – to uncover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback